Have your own idea? Try our Stock Screener
Australian (ASX) Healthcare Sector Analysis
UpdatedApr 22, 2026
DataAggregated Company Financials
Companies129
- 7D1.5%
- 3M-16.5%
- 1Y-27.3%
- YTD-17.7%
In the last week, the Healthcare industry is up 1.5%, with Sigma Healthcare up 4.4%. Meanwhile, 4DMedical actually underperformed within the industry, shrinking 19% in the last week. However, the industry is down 27% over the past year. Looking forward, earnings are forecast to grow by 23% annually.
Sector Valuation and Performance
Has the Australian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 23 Apr 2026 | AU$175.3b | AU$77.7b | AU$1.9b | 26.9x | 90.2x | 2.3x |
| Sat, 21 Mar 2026 | AU$170.9b | AU$78.0b | AU$2.0b | 25.4x | 87.2x | 2.2x |
| Mon, 16 Feb 2026 | AU$184.9b | AU$72.2b | AU$2.1b | 33.8x | 88x | 2.6x |
| Wed, 14 Jan 2026 | AU$213.8b | AU$73.8b | AU$4.5b | 31.8x | 47.5x | 2.9x |
| Fri, 12 Dec 2025 | AU$218.0b | AU$74.0b | AU$4.5b | 33.3x | 48.6x | 2.9x |
| Sun, 09 Nov 2025 | AU$221.6b | AU$75.0b | AU$4.6b | 32.9x | 48x | 3x |
| Tue, 07 Oct 2025 | AU$239.9b | AU$74.5b | AU$4.6b | 30.1x | 52.6x | 3.2x |
| Thu, 04 Sep 2025 | AU$238.6b | AU$74.9b | AU$4.6b | 32.1x | 52x | 3.2x |
| Sat, 02 Aug 2025 | AU$271.8b | AU$70.5b | AU$4.9b | 37.5x | 55.5x | 3.9x |
| Mon, 30 Jun 2025 | AU$251.6b | AU$71.7b | AU$4.3b | 26x | 59x | 3.5x |
| Wed, 28 May 2025 | AU$260.2b | AU$72.0b | AU$4.3b | 27.2x | 60.5x | 3.6x |
| Fri, 25 Apr 2025 | AU$246.5b | AU$70.7b | AU$4.9b | 27.2x | 50.3x | 3.5x |
| Sun, 23 Mar 2025 | AU$255.5b | AU$71.2b | AU$4.9b | 28.1x | 51.9x | 3.6x |
| Tue, 18 Feb 2025 | AU$241.1b | AU$65.9b | AU$3.5b | 29x | 68x | 3.7x |
| Thu, 16 Jan 2025 | AU$244.4b | AU$69.0b | AU$3.4b | 26.2x | 72.1x | 3.5x |
| Sat, 14 Dec 2024 | AU$242.8b | AU$68.3b | AU$3.3b | 26.3x | 73.6x | 3.6x |
| Mon, 11 Nov 2024 | AU$242.2b | AU$67.7b | AU$3.2b | 25.5x | 76.7x | 3.6x |
| Wed, 09 Oct 2024 | AU$242.7b | AU$67.1b | AU$3.1b | 28x | 79x | 3.6x |
| Fri, 06 Sep 2024 | AU$240.0b | AU$66.2b | AU$3.1b | 26.3x | 78x | 3.6x |
| Sun, 04 Aug 2024 | AU$242.8b | AU$63.3b | AU$2.7b | 29.6x | 90.2x | 3.8x |
| Tue, 02 Jul 2024 | AU$233.5b | AU$62.7b | AU$2.6b | 32.1x | 89.4x | 3.7x |
| Thu, 30 May 2024 | AU$221.4b | AU$61.1b | AU$2.6b | 28.2x | 83.7x | 3.6x |
| Sat, 27 Apr 2024 | AU$219.4b | AU$61.5b | AU$2.7b | 27.3x | 82.2x | 3.6x |
| Mon, 25 Mar 2024 | AU$222.2b | AU$61.8b | AU$2.7b | 26.2x | 83x | 3.6x |
| Wed, 21 Feb 2024 | AU$221.4b | AU$60.7b | AU$3.5b | 26.2x | 62.8x | 3.6x |
| Fri, 19 Jan 2024 | AU$221.2b | AU$60.5b | AU$2.9b | 24.9x | 77.5x | 3.7x |
| Sun, 17 Dec 2023 | AU$218.9b | AU$60.0b | AU$2.8b | 24.8x | 77.9x | 3.6x |
| Tue, 14 Nov 2023 | AU$200.5b | AU$61.2b | AU$3.0b | 24.5x | 67.3x | 3.3x |
| Thu, 12 Oct 2023 | AU$201.8b | AU$61.1b | AU$2.9b | 25.6x | 69.3x | 3.3x |
| Sat, 09 Sep 2023 | AU$210.4b | AU$61.3b | AU$2.9b | 25.8x | 72.4x | 3.4x |
| Mon, 07 Aug 2023 | AU$210.2b | AU$58.1b | AU$2.9b | 26.1x | 71.5x | 3.6x |
| Wed, 05 Jul 2023 | AU$216.8b | AU$57.7b | AU$2.9b | 28.6x | 75.1x | 3.8x |
| Fri, 02 Jun 2023 | AU$233.2b | AU$58.2b | AU$2.9b | 25.6x | 79.1x | 4x |
| Sun, 30 Apr 2023 | AU$230.5b | AU$57.4b | AU$2.9b | 29.2x | 79.5x | 4x |
Price to Earnings Ratio
79.5x
Current Industry PE
- Investors are optimistic on the Australian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 90.2x which is higher than its 3-year average PE of 70.4x.
- The 3-year average PS ratio of 3.5x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 13% per year over the last three years.
- Meanwhile revenues for these companies have grown 11% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Australian Healthcare sector?
| AU Market | 0.21% | |
| Healthcare | 1.54% | |
| Life Sciences | 9.74% | |
| Healthtech | 7.57% | |
| Pharma | 4.76% | |
| Healthcare Services | 3.52% | |
| Biotech | -0.18% | |
| Medical Equipment | -2.75% | |
Industry PE
- Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 2kx.
- Analysts are expecting annual earnings growth of 5.8%, which is lower than the prior year's growth of 92.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 49% over the next 5 years.
- This is better than its past earnings decline of 60% per year.
- In contrast, the Healthtech industry is expected to see its earnings grow by 5.8% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SIG Sigma Healthcare | AU$2.82 | 4.4% +AU$1.4b | -8.1% | PE54.1x | |
| PME Pro Medicus | AU$140.58 | 2.3% +AU$330.1m | -32.6% | PE62.6x | |
| PYC PYC Therapeutics | AU$1.29 | 6.2% +AU$73.7m | 24.8% | PS61.5x | |
| MSB Mesoblast | AU$2.21 | 1.8% +AU$60.2m | 30.0% | PS31.4x | |
| RHC Ramsay Health Care | AU$40.75 | 0.5% +AU$50.6m | 22.0% | PE34.3x |
